RESIDUAL DISEASE

Clinical trials for RESIDUAL DISEASE explained in plain language.

Never miss a new study

Get alerted when new RESIDUAL DISEASE trials appear

Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 1

New combo aims to wipe out remaining myeloma after transplant

Disease control Completed

This study looked at 42 people with multiple myeloma that remained after a stem cell transplant. It compared taking lenalidomide alone versus adding two other drugs (ixazomib and dexamethasone) to see if the combo could better clear the leftover cancer. The goal was to find a mor…

Matched conditions: RESIDUAL DISEASE

Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated May 11, 2026 20:48 UTC

RESIDUAL DISEASE

Get alerted when new RESIDUAL DISEASE trials appear

New combo aims to wipe out remaining myeloma after transplant